Search research articles
Contact Us
Filters
Showing results (211-220 of 249) with videos related to
Page
of 25
Sort By:
JMIR Mental Health
|
May 30, 2024
Tablet-Based Cognitive and Eye Movement Measures as Accessible Tools for Schizophrenia Assessment: Multisite Usability Study
Kentaro Morita, Kenichiro Miura, Atsuhito Toyomaki, et al.
The Lancet. Psychiatry
|
November 13, 2025
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
Richard S E Keefe, Philip D Harvey, Christoph U Correll, et al.
Bjpsych Open
|
June 3, 2022
Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre study
Chika Sumiyoshi, Kazutaka Ohi, Haruo Fujino, et al.
Neuroimage. Clinical
|
December 5, 2017
The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects
Naoki Hashimoto, Yoichi M Ito, Naohiro Okada, et al.
The International Journal of Neuropsychopharmacology
|
March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study
Shinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
November 4, 2016
Estimated cognitive decline in patients with schizophrenia: A multicenter study
Haruo Fujino, Chika Sumiyoshi, Yuka Yasuda, et al.
Neuropsychopharmacology Reports
|
December 2, 2021
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
Norio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, et al.
Asian Journal of Psychiatry
|
July 29, 2021
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project
Naoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Zoological Science
|
October 16, 2013
The diversity of shell matrix proteins: genome-wide investigation of the pearl oyster, Pinctada fucata
Hiroshi Miyamoto, Hirotoshi Endo, Naoki Hashimoto, et al.
BMC Psychiatry
|
May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
Toshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 249) with videos related to
Sort By:
Page
of 25
JMIR Mental Health
|
May 30, 2024
Tablet-Based Cognitive and Eye Movement Measures as Accessible Tools for Schizophrenia Assessment: Multisite Usability Study
Kentaro Morita, Kenichiro Miura, Atsuhito Toyomaki, et al.
The Lancet. Psychiatry
|
November 13, 2025
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
Richard S E Keefe, Philip D Harvey, Christoph U Correll, et al.
Bjpsych Open
|
June 3, 2022
Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre study
Chika Sumiyoshi, Kazutaka Ohi, Haruo Fujino, et al.
Neuroimage. Clinical
|
December 5, 2017
The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects
Naoki Hashimoto, Yoichi M Ito, Naohiro Okada, et al.
The International Journal of Neuropsychopharmacology
|
March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study
Shinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
November 4, 2016
Estimated cognitive decline in patients with schizophrenia: A multicenter study
Haruo Fujino, Chika Sumiyoshi, Yuka Yasuda, et al.
Neuropsychopharmacology Reports
|
December 2, 2021
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
Norio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, et al.
Asian Journal of Psychiatry
|
July 29, 2021
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project
Naoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Zoological Science
|
October 16, 2013
The diversity of shell matrix proteins: genome-wide investigation of the pearl oyster, Pinctada fucata
Hiroshi Miyamoto, Hirotoshi Endo, Naoki Hashimoto, et al.
BMC Psychiatry
|
May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
Toshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Page
of 25